Astera Labs (ALAB) Surges 13% on UALink Spec Update and Hyperscaler Deployments

Astera Labs delivered an impressive performance during Friday’s trading session. Shares opened with a gap higher and continued climbing into the mid-$140 range, a rally exceeding 13%, driven by industry developments, expanded customer adoption, and quarterly results that supported the company’s valuation.

Standards approval boosts AI interconnect outlook

The primary catalyst came from standards progression. The Ultra Accelerator Link Consortium formally approved revised UALink specifications that incorporate In-Network Compute capabilities. The approval reinforces Astera’s positioning as a provider of open-standard AI interconnect solutions and was viewed by market participants as validation that its technology will play a role in emerging data center architectures.

Customer selections extend adoption momentum

A secondary catalyst involved customer expansion. Two additional prominent hyperscalers confirmed they selected Astera’s Scorpio P-Series for upcoming AI infrastructure deployments. The selections add to the company’s enterprise-scale implementation pipeline and suggest adoption momentum is broadening beyond initial customers.

Quarterly results support premium valuation

The impact of these catalysts was reinforced by Astera’s recent financial performance. In its fourth-quarter results released last February, the company reported earnings per share of $0.58 versus the $0.51 Wall Street consensus. Revenue totaled $270.58 million, above the $249.46 million analyst estimate, representing 91.8% growth versus the prior-year quarter.

For first-quarter 2026, management guided EPS between $0.530 and $0.540. Profitability metrics remained strong, with net margin at 25.70% and return on equity at 16.12%.

Market metrics and trading levels

With a market capitalization near $25 billion, Astera’s shares trade at a price-to-earnings multiple of 119.54, reflecting a premium valuation tied to elevated growth expectations. The 200-day moving average is $156.21, placing it above Friday’s closing level and indicating the stock is working to recover from a correction that began earlier this year. Year-to-date, ALAB is down approximately 22% prior to Friday’s advance.

The 50-day moving average is $128.14.

Analyst sentiment and price targets

Street sentiment is broadly positive. Of 22 analysts covering the stock, 15 rate it Buy, six rate it Hold, and one rates it Sell. The consensus price target is $199.44.

Recent coverage actions include Citigroup, which began coverage on April 2 with a Buy rating and a $200 price objective, and Loop Capital, which initiated coverage on March 5 with a Buy rating and a $250 target. Royal Bank of Canada set an Outperform rating with a $225 target in January. Barclays maintains a $165 price objective, while Weiss Ratings downgraded to Sell during February.

Insider and institutional activity

Insider transactions reported include CEO Jitendra Mohan selling 157,500 shares on March 17 at an average execution price of $131.58. General Counsel Philip Mazzara sold 10,000 shares on April 1 at $107.77 under a pre-established Rule 10b5-1 trading arrangement. Collectively, insiders have sold approximately 577,000 shares valued around $69.5 million over the trailing 90-day period. Current insider ownership is 12.50% of outstanding shares.

Institutional investors hold 60.47% of the company. Vanguard increased its stake by 14.1% during the third quarter, while Atreides Management increased its position by more than 2,400% in the fourth quarter.